ReportGem ReportGem

U.S. COMPANY FILING

NORTHROP GRUMMAN CORP /DE/ — Form 8-K filed 2025-11-06

Filed: 2025-11-06Company: NORTHROP GRUMMAN CORP /DE/Ticker: NOCExchange: NYSEForm: 8-KReport period: 2025-11-03SEC accession: 0001628280-25-050297Event: governanceMateriality: 0

Filing text preview

Northrop Grumman announced on November 3, 2025, the election of John Greene as CFO, effective January 7, 2026, succeeding Kenneth Crews, who will remain in an advisory role until February 20, 2026. Greene's compensation includes a $955,000 base salary and a $2,000,000 sign-on grant. The company reaffirmed its FY2025 guidance.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record

Related research and intelligence

Official SEC filing2025-11-06Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy2026-08-20FDA Approves Regeneron's (REGN) Pasatru for Ultra-Rare FOP in August 2026; Shares Up 5.4%2026-08-20Nocera Files 8-K Disclosing Material Agreement and Management Changes2026-08-20Sinocell: SCTB10 injection obtains clinical trial approval2026-08-19Sinocell: Subsidiary SCTA02A Injection Gets Clinical Trial Approval2026-08-19Sinocell: Subsidiary SCTB10 Gets Clinical Trial Approval for Hemophilia A2026-08-1910-Q2026-07-21 · 10-Q